skip to main content

    Updated Visitor Guidelines

 

MENU

 

Maize and Blue GO PINK Recap of an Unforgettable Event

The information on this page has expired. To learn about supporting the University of Michigan, please visit the Leaders and Best website.

Director's Message - Winter, 2014

The information on this page has expired. To learn more about the U-M Rogel Cancer Center, visit our About Us section.

When pain lingers after breast cancer treatment

About a quarter of women experience moderate to severe pain for many years after their treatment ends. In many cases, it's a type of pain that is challenging to treat, with few or no effective options.

Liquid biopsy could improve cancer diagnosis and treatment

A microfluidic chip developed at the University of Michigan is among the best at capturing elusive circulating tumor cells from blood -- and it can support the cells' growth for further analysis.

Prostate Cancer Study

The information on this page has expired. To learn about more recent advancements in research at the U-M Rogel Cancer Center, visit our news archive.

U-M offers new early detection test for prostate cancer

Michigan Medicine has begun offering a new urine test called Mi-Prostate Score to improve on PSA screening for prostate cancer. The test incorporates three specific markers that could indicate cancer and studies have shown that the combination is far more accurate than PSA alone.

Are patients making cost-effective treatment decisions?

Recent studies have suggested that an informed patient will be less likely to choose a more-extensive treatment than what the doctor recommends but a recent study by University of Michigan Rogel Cancer Cetner researchers have found that's not necessarily the case.

2 U-M researcher teams receive funds from Movember

U-M Cancer Center director to step down

After 27 years leading the University of Michigan Rogel Cancer Center, founding director Max S. Wicha, M.D., has announced that he will step down as director. While serving as director, Wicha has continued to maintain his laboratory research and clinical practice seeing patients with breast cancer. In 2003, he was part of the team that first identified breast cancer stem cells.

Pages